Dr. Clay Moss: On Metabolic Health, Insulin Resistance, Peptides, & Sleep Hygiene | TUH #267
About this video
Brecka interviews functional medicine physician Dr. Clay Moss about metabolic health as, in Moss’s framing, the root of most chronic disease. Moss argues that looking fit does not guarantee metabolic health, points to fasting insulin and insulin resistance as early warning signals, and presents muscle and strength training as central to longevity. They also discuss comfort as a driver of illness, visceral fat and body composition testing, and Moss’s view that GLP-1 medicines and peptides may have a place when used in a clinical setting alongside training.
Key takeaways
- Brecka and Moss claim fasting insulin can flag metabolic problems earlier than standard markers
- Moss argues muscle is protective medicine, not just an aesthetic goal
- Moss states he moved from opposing GLP-1s to seeing them as one tool among others, per the discussion
- Both frame movement, food, stress and community as foundational before advanced interventions
Episode details: published May 5, 2026 · 60.2K views · 1:10:20 long. Summary written by Self Growth Videos from the episode itself. Gary Brecka is a commercial health figure, not a physician. The claims described are Brecka’s or his guests’, presented for education — not medical advice and not endorsed by Self Growth Videos. Consult a qualified professional before changing your own health practices.
← Previous: What’s Actually In My Fridge · Next: The Most Dangerous Drug Is Comfort →
All Gary Brecka videos · Gary Brecka profile · The Ultimate Human (official site)
You Might Also Enjoy

Q&A with Gary Brecka: Peptides, Migraines, Sleep Protocols & More! | TUH #240
Explore →
Dr. Austin Lake: Women’s Health - Birth Control, Hormones, Sleep & Nutrients | TUH #145
Explore →
Dr. Tyna Moore: The TRUTH About Metabolic Health Nobody Is Talking About | TUH #109
Explore →
The GLP-1 Side Effect Nobody Warns You About | TUH #291
Explore →
Brigham Buhler: The Peptide Safety Data Reveals 75,000+ Patients With Zero Adverse Events |TUH #182
Explore →